Table V.
Gene expression levels in the NOWS cohort as stratified on the basis of pharmacotherapy and sex
NOWS cohort | Gene names | Male | Female | P values |
---|---|---|---|---|
| ||||
NOWS-No-Pharm | n = 34 | n = 16 | n = 18 | |
NPY2R | 8.6 ± 4.8 | 7.6 ± 4.8 | .57 | |
DRD2 | 10.2 ± 4.1 | 13.3 ± 4.0 | .03 | |
LEPR | 8.4 ± 3.3 | 8.1 ± 2.8 | .75 | |
POMC | 10.7 ± 4.5 | 10.5 ± 4.0 | .86 | |
NOWS-Pharm | n = 16 | n = 11 | n = 5 | |
NPY2R | 10.1 ± 5.0 | 9.9 ± 6.3 | .94 | |
DRD2 | 11.7 ± 3.4 | 15.9 ± 0.9 | .02 | |
LEPR | 8.4 ± 2.5 | 12.4 ± 5.1 | .05 | |
POMC | 11.8 ± 4.2 | 12.4 ± 4.3 | .81 |
ΔCt values are in mean ± SD; bolded values indicate significance.